Medex Announces Third Quarter 2004 Conference Call

CARLSBAD, Calif., Nov. 1 /PRNewswire/ -- Medex, Inc. intends to file its Quarterly Report on Form 10-Q for the quarter and nine months ended September 25, 2004 with the Securities and Exchange Commission on Tuesday, November 9, 2004.

The Company will host a conference call at 4:30pm EST on Wednesday, November 10, 2004, with Dominick Arena, President and Chief Executive Officer, and Michael Dobrovic, Chief Financial Officer, to discuss details regarding the Company's performance for the quarter and nine months ended September 25, 2004. Individuals wishing to participate in this call should dial (888) 455-5419 or (630) 395-0018; the passcode is MEDEX. This call will be recorded, with replay instructions and a transcript available on the Company's website at http://www.medex.com/. Individuals interested in obtaining replay instructions or a transcript should contact Gregory Aranaga at (760) 602-4455 or visit http://www.medex.com/ for more information.

About Medex

Medex is a global manufacturer and marketer of critical care and alternate care medical products used in both acute and alternate care settings for a variety of therapeutic, diagnostic and long-term procedures. Medex markets and sells critical care systems and products to over 5,500 hospitals, health care systems, and alternate healthcare settings in more than 75 countries through a global sales force and distribution network. Headquartered in Carlsbad, California, the Company employs approximately 2,000 people worldwide.

Forward-Looking Statements

This news release contains certain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results and performance to be materially different from any future results or performance expressed or implied by these forward-looking statements. Detailed information about such risk factors is set forth in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to update, alter or release publicly any revisions to its forward-looking statements, whether as a result of new information, subsequent events or developments.

Contact: Gregory Aranaga Director, Corporate Communications +1 760.602.4455 garanaga@medex.comhttp://www.medex.com/

Medex, Inc.

CONTACT: Gregory Aranaga, Director, Corporate Communications of Medex,Inc., +1-760-602-4455, garanaga@medex.com

Back to news